Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

Heterologous primary immunization against SARS-CoV-2 is part of applied recommendations. However, little is known about duration of immune responses after heterologous vaccine regimens. To evaluate duration of immune responses after primary vaccination with homologous adeno-vectored ChAdOx1 nCoV-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Marking, Ulrika, Havervall, Sebastian, Greilert-Norin, Nina, Ng, Henry, Blom, Kim, Nilsson, Peter, Phillipson, Mia, Hober, Sophia, Nilsson, Charlotta, Mangsbo, Sara, Christ, Wanda, Klingström, Jonas, Gordon, Max, Åberg, Mikael, Thålin, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953845/
https://www.ncbi.nlm.nih.gov/pubmed/35334989
http://dx.doi.org/10.3390/vaccines10030359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953845/
https://www.ncbi.nlm.nih.gov/pubmed/35334989
http://dx.doi.org/10.3390/vaccines10030359

Ejemplares similares